Efficacy of 5-fluorouracil (5-FU) and low molecular weight heparin (LMWH) in high-risk pediatric retinal detachment; randomized clinical trial

被引：0
|
作者：
Mohamed Nasr
Ahmed Abdelhadi
Amr Bessa
Tamer Moussa Ibrahim
机构：
[1] Alexandria University,Department of Ophthalmology, Faculty of Medicine
来源：
BMC Ophthalmology | / 24卷
关键词：
Pediatric retinal detachment; Proliferative vitreoretinopathy; 5-fluorouracil; Low molecular weight heparin; Recurrent retinal detachment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] CLINICAL-EXPERIENCE WITH 5-FLUOROURACIL (5-FU) AND HIGH-DOSE FOLINIC ACID IN SOLID TUMORS
    MARINI, G
    ZANIBONI, A
    GORNI, F
    MARPICATI, P
    MONTINI, E
    SIMONCINI, E
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1987, 13 (06) : 373 - 376
  • [22] Does cisplatin (CDDP) function as a modulator of 5-fluorouracil (5-FU) antitumor action? A study based on a clinical trial
    Matsusaka, S
    Nagareda, T
    Yamasaki, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (04) : 387 - 392
  • [23] Does cisplatin (CDDP) function as a modulator of 5-fluorouracil (5-FU) antitumor action? A study based on a clinical trial
    Satoshi Matsusaka
    Tomofumi Nagareda
    Hajime Yamasaki
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 387 - 392
  • [24] CYCLOPHOSPHAMIDE (CTX) VERSUS 5-FLUOROURACIL (5-FU), ADRIAMYCIN (ADR) AND CTX IN TREATMENT OF METASTATIC PROSTATIC CARCINOMA - RANDOMIZED TRIAL
    CHLEBOWSKI, RT
    HESTORFF, R
    SADOFF, L
    WEINER, JM
    BATEMAN, JR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 68 - 68
  • [25] A PROSPECTIVE RANDOMIZED (NCOG-RTOG) TRIAL OF CONVENTIONAL SPLIT COURSE RADIOTHERAPY WITH 5-FLUOROURACIL (5-FU) VERSUS HELIUM ION RADIOTHERAPY WITH 5-FU (A PRELIMINARY-REPORT)
    QUIVEY, JM
    CASTRO, JR
    SAUNDERS, WB
    CHEN, GT
    LYMAN, JT
    WOODRUFF, KH
    HANNIGAN, JF
    GRIBBLE, MJ
    HOFFMAN, K
    CARTER, SK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 460 - 460
  • [26] PRE-TREATMENT WITH TOPICAL 5 FLUOROURACIL (5-FU) ENHANCES THE EFFICACY OF ALA PDT FOR THE TREATMENT OF ACTINIC KERATOSES; RESULTS OF A RANDOMIZED, CONTROLLED CLINICAL TRIAL WITH POST-TREATMENT 5-FU CHALLENGE
    Tanghetti, Emil
    Tanghetti, Margo
    LASERS IN SURGERY AND MEDICINE, 2014, 46 : 46 - 46
  • [27] Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy Results from a Randomized Clinical Trial
    Schaub, Friederike
    Schiller, Petra
    Hoerster, Robert
    Kraus, Daria
    Holz, Frank G.
    Guthoff, Rainer
    Agostini, Hansjurgen
    Spitzer, Martin S.
    Wiedemann, Peter
    Lommatzsch, Albrecht
    Boden, Karl T.
    Dimopoulos, Spyridon
    Bemme, Sebastian
    Tamm, Svenja
    Maier, Mathias
    Roider, Johann
    Enders, Philip
    Altay, Lebriz
    Fauser, Sascha
    Kirchhof, Bernd
    OPHTHALMOLOGY, 2022, 129 (10) : 1129 - 1141
  • [28] Effect of 5-fluorouracil and low molecular weight heparin on an improved proliferative vitreoretinopathy model in the rabbit
    Pimentel, S
    Hartzer, M
    ElRayes, E
    Pendergast, SD
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 1822 - 1822
  • [29] COMBINATION MITOMYCIN-C (MMC) AND 5-FLUOROURACIL (5FU) THERAPY ADJUNCTIVE TO HIGH-RISK TRABECULECTOMY
    LIN, SA
    KIM, SY
    SINGH, K
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S86 - S86
  • [30] Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987)
    Nitti, D
    Wils, J
    Sahmoud, T
    Curran, D
    Couvreur, ML
    Lise, M
    Rauschecker, H
    dosSantos, JG
    Stremmel, W
    Roelofsen, F
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1209 - 1215
12345